Vimta Labs Limited (IN:VIMTALABS)
:VIMTALABS
Want to see IN:VIMTALABS full AI Analyst Report?
VIMTALABS Stock Chart & Stats
₹609.25
-₹18.70(-1.83%)
At close: 4:00 PM EST
₹609.25
-₹18.70(-1.83%)
Day’s Range― - ―
52-Week Range₹377.30 - ₹902.85
Previous CloseN/A
Volume71.13K
Average Volume (3M)22.50K
Market Cap
₹20.43B
Enterprise Value₹20.43B
Total Cash (Recent Filing)₹564.64M
Total Debt (Recent Filing)₹67.97M
Price to Earnings (P/E)38.2
Beta1.06
Next Earnings
May 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.16%
Share Statistics
EPS (TTM)3.94
Shares Outstanding44,669,353
10 Day Avg. Volume11,086
30 Day Avg. Volume22,501
Financial Highlights & Ratios
PEG Ratio0.25
Price to Book (P/B)2.83
Price to Sales (P/S)3.12
P/FCF Ratio68.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High ProfitabilitySustained, high operating and EBITDA margins reflect durable pricing power and efficient lab operations in fee-for-service testing. Strong margins provide internal cash to fund compliance, personnel and equipment, cushioning the business against sector cyclicality over months.
Conservative Balance SheetExtremely low leverage and a high equity ratio give the company financial resilience and optionality. This conservatism reduces interest burden and supports investment in capacity, M&A or downturns without jeopardizing financial flexibility over a multi-month horizon.
Improving Cash GenerationA shift to positive free cash flow and strong operating cash conversion of earnings indicate improving cash quality. Reliable cash generation supports reinvestment in labs, working capital needs and modest shareholder returns without depending heavily on external financing.
Bears Say
Modest Free Cash Flow RetentionAlthough FCF turned positive, retention remains modest which limits the firm’s ability to self-fund larger expansions, sustain higher dividends, or accelerate capacity additions. Over several months this constrains strategic reinvestment flexibility.
Moderate Revenue GrowthSingle-digit top-line growth, while positive, is moderate for a diagnostics and research services provider. Slower revenue expansion can limit scale economies and the pace at which profitability improvements translate into higher absolute cash flow over the medium term.
Undisclosed Customer/Segment ConcentrationLack of disclosure on major customers or segment splits raises visibility risk. If revenue depends on a few large clients, contract loss or pricing pressure could materially affect results, increasing revenue volatility and execution risk over a multi-month horizon.
Vimta Labs Limited News
VIMTALABS FAQ
What was Vimta Labs Limited’s price range in the past 12 months?
Vimta Labs Limited lowest stock price was ₹377.30 and its highest was ₹902.85 in the past 12 months.
What is Vimta Labs Limited’s market cap?
Vimta Labs Limited’s market cap is ₹20.43B.
When is Vimta Labs Limited’s upcoming earnings report date?
Vimta Labs Limited’s upcoming earnings report date is May 30, 2026 which is in 31 days.
How were Vimta Labs Limited’s earnings last quarter?
Vimta Labs Limited released its earnings results on Jan 28, 2026. The company reported ₹3.94 earnings per share for the quarter, beating the consensus estimate of N/A by ₹3.94.
Is Vimta Labs Limited overvalued?
According to Wall Street analysts Vimta Labs Limited’s price is currently Overvalued.
Does Vimta Labs Limited pay dividends?
Vimta Labs Limited pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.16%. See more information on Vimta Labs Limited dividends here
What is Vimta Labs Limited’s EPS estimate?
Vimta Labs Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vimta Labs Limited have?
Vimta Labs Limited has 44,669,353 shares outstanding.
What happened to Vimta Labs Limited’s price movement after its last earnings report?
Vimta Labs Limited reported an EPS of ₹3.94 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -10.196%.
Which hedge fund is a major shareholder of Vimta Labs Limited?
Currently, no hedge funds are holding shares in IN:VIMTALABS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vimta Labs Limited
Vimta Labs Limited provides contract research and testing services in India and internationally. It offers laboratory, food and water testing and analysis, preclinical and clinical research, biological molecule structural and functional analysis, environmental assessment, and clinical reference laboratory services. The company serves pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and various other industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.
Technical Analysis
Indoco Remedies Limited
―
Krsnaa Diagnostics Limited
―
Sakar Healthcare Ltd
―
SMS Pharmaceuticals Limited
―
Solara Active Pharma Sciences Ltd.
―